Congenital Heart Disease

• FDA approval · 2014-06-09
  FDA Approved: PROSTIN VR PEDIATRIC — Supplemental Application (Pharmacia & Upjohn Company LLC)

  The FDA approved a supplemental application for PROSTIN VR PEDIATRIC (alprostadil) from Pharmacia & Upjohn Company LLC.

• FDA approval · 2011-04-04
  FDA Approved: SYNAGIS — Supplemental Application (Swedish Orphan Biovitrum AB (publ))

  The FDA approved a supplemental application for Synagis (palivizumab) filed by Swedish Orphan Biovitrum AB (publ).